Understanding the Restructure of US Pharmacy Benefits Amid Reform, Regulatory Action

Aug 13, 12:00 PM
Subscribe
Rae McMahan joins Over the Counter to discuss recent regulatory action involving CVS Caremark and the Federal Trade Commission, exploring what the collection of PBM reform efforts means for the greater pharmacy industry moving forward.